ACHV
Achieve Life Sciences Inc
7.00$
-3.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.7% | +0.0% | +0.0% | +0.0% | +1.8% | +6.9% | -11.3% | -1.8% | +5.6% | +0.0% | +1.8% | – | |
| – | -100.9% | – | +12.9% | -7.8% | -7.2% | +79.6% | +29.4% | -19.0% | -44.4% | -152.7% | – | – | |
| – | +3,350.0% | -1,071.0% | – | -155.5% | – | -146.9% | – | +0.3% | -903.7% | – | -92.2% | – | |
| – | -60.0% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | |
| – | -60.0% | – | – | – | -11.7% | -3.1% | -41.0% | -288.8% | – | +1,913.5% | -1,065.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.3% | +5,202.0% | – | -100.0% | – | -90.2% | +54.9% | -99.7% | +802,081.0% | – | |
| – | – | – | -201.6% | – | – | -91.8% | +14,674.9% | -151.3% | – | – | +178.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.